Tetracyclines in pediatrics revisited. - Wikidata - awgldk - TriplyDB

Tetracyclines in pediatrics revisited.

Tetracyclines in pediatrics revisited.

http://www.wikidata.org/entity/Q53969308

about

Pediatric anthrax clinical management Side effects of minocycline treatment in patients with fragile X syndrome and exploration of outcome measures Can accidental local application of a drug cause discolouration of permanent teeth?Sensory Processing Phenotypes in Fragile X Syndrome

P2860

Q28397091-CB653E47-68F6-4FEF-8845-9CFF2D940C23 Q33650170-56B884A5-1BA2-44A1-8578-33C5FD96DB20 Q41940292-695F58A5-1C40-4ED4-9C8C-44149C2E7041 Q58718525-251FF9AA-EC65-48D7-9209-9F020CC55D55

P2860

Tetracyclines in pediatrics revisited.

http://www.wikidata.org/entity/Q53969308

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Tetracyclines in pediatrics revisited.

@en

Tetracyclines in pediatrics revisited.

@nl

type

label

Tetracyclines in pediatrics revisited.

@en

Tetracyclines in pediatrics revisited.

@nl

prefLabel

Tetracyclines in pediatrics revisited.

@en

Tetracyclines in pediatrics revisited.

@nl

P1433

Q53969308-D2087194-B544-4172-9438-09B097EDE2C2

P1476

Q53969308-FCD34C0E-5DED-4DBE-AF34-3F9F1C8925DB

P2093

Q53969308-71C8179B-90D0-4980-B442-A99ACD5E2BB6

P2860

Q53969308-0D566F89-751A-493D-95C4-2BAF9E3893DF

Q53969308-0EFD07E5-E3A6-4A91-93F7-97BC94A43D74

Q53969308-1309FED1-01B3-45C4-9290-C4EF22D2ACE1

Q53969308-1A6F4EC2-7320-4310-B142-068DFC928A7C

Q53969308-2B913FB9-EFA9-4001-A611-6E1BAB291DBF

Q53969308-32910DF1-3599-49BE-9FD9-D261B5001DDE

Q53969308-63948998-3F97-411E-8AA2-D7AA204CA4FD

Q53969308-647004B0-96DB-4FF1-872F-8F9253FE8F8E

Q53969308-6E57F308-5490-4CD1-8D6D-49290F7BCFD6

Q53969308-78E55CA8-B73E-4C77-B8E5-C29345CDCE52

P304

Q53969308-961E0104-0FB2-4083-84EF-5CB23B696C44

P31

Q53969308-546909C1-6719-407C-A26E-23E6EBC99E66

P356

Q53969308-DE9E76C1-B869-4216-9E1D-DB38CB8C3DA1

P433

Q53969308-E5132F0D-A296-430D-B337-39BDF5A2C59A

P478

Q53969308-4C2B9191-C9A8-4012-817E-B1C19E6C1656

P577

Q53969308-9360D642-1F24-48ED-8C3B-CAA740A0230F

P698

Q53969308-0C307E90-B65F-463F-BC8C-E08B1F130E3A

P356

000992280204100402

P1433

Clinical Pediatrics

P1476

Tetracyclines in pediatrics revisited.

@en

P2093

Avinash K Shetty

http://www.w3.org/2001/XMLSchema#string

P2860

New uses of older antibiotics.

The tetracyclines.

Antimicrobial susceptibility of coagulase-negative staphylococci.

Doxycycline use for rickettsial disease in pediatric patients.

Tetracyclines, molecular and clinical aspects.

Antimicrobial therapy of rickettsial diseases

In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.

Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy.

Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988.

Tetracyclines: antibiotic action, uptake, and resistance mechanisms.

P304

203-209

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/000992280204100402

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12041715

http://www.w3.org/2001/XMLSchema#string